The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC)

Published:2016-12 Issue:50 Volume:95 Page:e5599
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yang Jiaying,He Jieyu,Yu Miao,Li Taishun,Luo Li,Liu Pei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference61 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease;Besse;Ann Oncol,2014

3. Optimizing first-line treatment options for patients with advanced NSCLC;Wakelee;Oncologist,2005

4. Phase III randomized trial comparing three platinum-based doublets in advanced non–small-cell lung cancer;Scagliotti;J Clin Oncol,2002

5. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes;Le Chevalier;Lung Cancer,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of bacterial signaling networks in antibiotics response and resistance regulation;Marine Life Science & Technology;2022-03-28

2. Regulatory Mechanisms of the LuxS/AI-2 System and Bacterial Resistance;Antimicrobial Agents and Chemotherapy;2019-10

3. Efficacy of erlotinib and celecoxib for patients with advanced non-small cell lung cancer;Medicine;2019-03

4. Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients;Medicines;2018-09-06

5. Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis;PLOS ONE;2018-08-27